Literature DB >> 17265188

Anterior pituitary hormone replacement therapy--a clinical review.

Christoph J Auernhammer1, George Vlotides.   

Abstract

This clinical review summarizes current approaches to diagnosis and treatment of anterior pituitary hormone deficiency. The diagnostic value of endocrine function tests and replacement strategies for hydrocortisone, thyroxine, sex steroids, and growth hormone replacement are reviewed. Female androgen deficiency syndrome and the current role of DHEA and testosterone replacement in women are also discussed.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17265188     DOI： 10.1007/s11102-007-0001-6

Source DB:  PubMed          Journal:  Pituitary        ISSN： 1386-341X            Impact factor:   4.107


  170 in total

1.  Effects of 10 years of growth hormone (GH) replacement therapy in adult GH-deficient men.

Authors:  Lucia I Arwert; Jan C Roos; Paul Lips; Jos W R Twisk; Radu A Manoliu; Madeleine L Drent
Journal:  Clin Endocrinol (Oxf)       Date:  2005-09       Impact factor: 3.478

2.  Influence of body mass index and gender on growth hormone (GH) responses to GH-releasing hormone plus arginine and insulin tolerance tests.

Authors:  Xiao-Dan Qu; Irene T Gaw Gonzalo; Mohammed Y Al Sayed; Pejman Cohan; Peter D Christenson; Ronald S Swerdloff; Daniel F Kelly; Christina Wang
Journal:  J Clin Endocrinol Metab       Date:  2004-12-21       Impact factor: 5.958

3.  Growth hormone (GH) substitution in GH-deficient patients inhibits 11beta-hydroxysteroid dehydrogenase type 1 messenger ribonucleic acid expression in adipose tissue.

Authors:  Søren Kildeberg Paulsen; Steen Bønløkke Pedersen; Jens Otto Lunde Jørgensen; Sanne Fisker; Jens Sandahl Christiansen; Allan Flyvbjerg; Bjørn Richelsen
Journal:  J Clin Endocrinol Metab       Date:  2005-12-20       Impact factor: 5.958

Review 4.  Pituitary insufficiency.

Authors:  S W Lamberts; W W de Herder; A J van der Lely
Journal:  Lancet       Date:  1998-07-11       Impact factor: 79.321

5.  Efficacy and safety of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women: a randomized, placebo-controlled trial.

Authors:  Susan R Davis; M J van der Mooren; Rik H W van Lunsen; Patrice Lopes; Claude Ribot; Jean Ribot; Margaret Rees; Alain Moufarege; Cynthia Rodenberg; Akshay Buch; David W Purdie
Journal:  Menopause       Date:  2006 May-Jun       Impact factor: 2.953

6.  Evaluation of the adequacy of levothyroxine replacement therapy in patients with central hypothyroidism.

Authors:  E Ferretti; L Persani; M L Jaffrain-Rea; S Giambona; G Tamburrano; P Beck-Peccoz
Journal:  J Clin Endocrinol Metab       Date:  1999-03       Impact factor: 5.958

7.  The effects of treatment and the individual responsiveness to growth hormone (GH) replacement therapy in 665 GH-deficient adults. KIMS Study Group and the KIMS International Board.

Authors:  B A Bengtsson; R Abs; H Bennmarker; J P Monson; U Feldt-Rasmussen; E Hernberg-Stahl; B Westberg; P Wilton; C Wüster
Journal:  J Clin Endocrinol Metab       Date:  1999-11       Impact factor: 5.958

8.  Assessing the HPA axis in patients with pituitary disease: a UK survey.

Authors:  Rebecca M Reynolds; Paul M Stewart; Jonathan R Seckl; Paul L Padfield
Journal:  Clin Endocrinol (Oxf)       Date:  2006-01       Impact factor: 3.478

9.  A new sustained-release preparation of human growth hormone and its pharmacokinetic, pharmacodynamic and safety profile.

Authors:  Andreas Jostel; Annice Mukherjee; Jan Alenfall; Linda Smethurst; Stephen M Shalet
Journal:  Clin Endocrinol (Oxf)       Date:  2005-05       Impact factor: 3.478

10.  Healthcare consumption decreases in parallel with improvements in quality of life during GH replacement in hypopituitary adults with GH deficiency.

Authors:  E Hernberg-Ståhl; A Luger; R Abs; B A Bengtsson; U Feldt-Rasmussen; P Wilton; B Westberg; J P Monson
Journal:  J Clin Endocrinol Metab       Date:  2001-11       Impact factor: 5.958
View more
  2 in total

1.  Management of cavernous sinus meningiomas: Consensus statement on behalf of the EANS skull base section.

Authors:  Marco V Corniola; Pierre-Hugues Roche; Michaël Bruneau; Luigi M Cavallo; Roy T Daniel; Mahmoud Messerer; Sebastien Froelich; Paul A Gardner; Fred Gentili; Takeshi Kawase; Dimitrios Paraskevopoulos; Jean Régis; Henry W S Schroeder; Theodore H Schwartz; Marc Sindou; Jan F Cornelius; Marcos Tatagiba; Torstein R Meling
Journal:  Brain Spine       Date:  2022-01-21

2.  Prediction of Long-term Post-operative Testosterone Replacement Requirement Based on the Pre-operative Tumor Volume and Testosterone Level in Pituitary Macroadenoma.

Authors:  Cheng-Chi Lee; Chung-Ming Chen; Shih-Tseng Lee; Kuo-Chen Wei; Ping-Ching Pai; Cheng-Hong Toh; Chi-Cheng Chuang
Journal:  Sci Rep       Date:  2015-11-05       Impact factor: 4.379
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.